Pharmaceuticals, Biotechnology and Life Sciences
– Leverages Strata Oncology’s Proprietary Biomarker Technology to Stratify Patients – HAYWARD, Calif. and ANN ARBOR, Mich.–(BUSINESS WIRE)–Arcus Biosciences, Inc.…
– Update Reflects Alignment with FDA on Path to Full Approval for Treatment of PH1 and Discussions Now Focusing on…
Eli Lilly will present 19 scientific abstracts for headache preventive drug Emgality (galcanezumab-gnlm) and lasmiditan at the 71st Annual Meeting of the American Academy of Neurology (AAN) taking place in Philadelphia from May 4-10, 2019.
Enrolled first patient in National Cancer Institute (NCI)-sponsoredPhase 3 trial of uproleselan in older adults with previously untreatedacute myeloid leukemia (AML)
Data presented during “The Role of the Tie2 Pathway in Ocular Disease” symposium at the Association for Research in Vision…
Conference Call Scheduled Today at 8:30 a.m. ET LEXINGTON, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24CNCE&src=ctag" target="_blank"gt;$CNCElt;/agt; lt;a href="https://twitter.com/hashtag/CNCE?src=hash" target="_blank"gt;#CNCElt;/agt;–Concert Pharmaceuticals, Inc. (NASDAQ: CNCE)…
– Ironwood launches as GI-focused healthcare company following separation of Cyclerion Therapeutics on April 1, 2019 – – First quarter…
Focusing on ‘Make Transformation Happen’, AMPLEXOR’s annual event line-up of life sciences thought leaders will present strategies and best practices…
WATERTOWN, Mass.–(BUSINESS WIRE)–Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel tetracyclines to treat serious and…
– Biodistribution of RP-A501 Demonstrates High Concentration in Heart, the End-Organ Target in Danon Disease – – Phase 1 Clinical…